To provide funds to the Centers for Medicare & Medicaid Services to provide grants to entities to establish lung cancer screening registries approved by the Centers for Medicare & Medicaid Services for submission of certain data required for reimbursement under the Medicare program for certain screening services, and for other purposes.

Grants— There is appropriated to the Centers for Medicare & Medicaid Services, out of any moneys in the Treasury not otherwise appropriated, $2,000,000 for each of fiscal years 2021 through 2025 to make grants to entities to establish and carry out registries that are approved by the Centers for Medicare & Medicaid Services as meeting the requirements described in the Final National Coverage Determination on Screening for Lung Cancer with Low Dose Computed Tomography published on February 5, 2015.

Limitation— As a condition of receiving a grant pursuant to subsection (a), with respect to a registry described in such subsection, an entity may not charge any fee for access to such registry.

requiring interoperability as a condition of receiving any Federal funding for such a registry; and

revoking any such funding for such a registry if the registry is not interoperable with other such registries.

In general— Subject to subsection (c), the Secretary of Health and Human Services shall award competitive grants to organizations with quality measure development expertise to develop, using data contained in registries described in section 1(a) (including such a registry established using funds provided under such section), quality and efficiency measures described in subsection (b) for review and potential endorsement by a consensus-based entity with a contract in effect under section 1890 of the Social Security Act (42 U.S.C. 1395aaa) for uses including as described in subsection (b)(7)(B) of such section.

Quality and efficiency measures described— For purposes of subsection (a), quality and efficiency measures described in this subsection are quality and efficiency measures to improve health care efficiency and outcomes with respect to lung cancer screening practices, early detection of lung cancer, and lung cancer prevention.

Authorization of appropriations— There is authorized to be appropriated to carry out subsection (a) $1,000,000 for each of fiscal years 2021 through 2025.